| NCT ID | NCT06935084 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Montefiore Medical Center |
| Condition | Asthma |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2025-09-18 |
| Primary Completion | 2028-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2025-09-18 with a primary completion date of 2028-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study is to conduct a randomized controlled trial (RCT) to compare the adapted and refined ASTHMAXcel Voice platform to usual care (UC). It is hypothesized by the investigator team that ASTHMAXcel Voice will be associated with improved clinical and process outcomes, asthma quality of life (QOL), medication adherence, and self-efficacy as compared to UC.
Eligibility Criteria
Inclusion Criteria: * English speaking * Persistent asthma (diagnosed by a healthcare provider) on a daily controller medication * Able to provide informed consent * Smartphone access (iOS or Android) with data plan Exclusion Criteria: * Pregnancy * Severe psychiatric or cognitive problems that would prohibit completion of protocol
Contact & Investigator
Sunit Jariwala, MD
PRINCIPAL INVESTIGATOR
Montefiore Medical Center
Frequently Asked Questions
Who can join the NCT06935084 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Asthma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06935084 currently recruiting?
Yes, NCT06935084 is actively recruiting participants. Contact the research team at sjariwal@montefiore.org for enrollment information.
Where is the NCT06935084 trial being conducted?
This trial is being conducted at The Bronx, United States.
Who is sponsoring the NCT06935084 clinical trial?
NCT06935084 is sponsored by Montefiore Medical Center. The principal investigator is Sunit Jariwala, MD at Montefiore Medical Center. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.